e-learning
resources
Vienna 2003
Monday 29.09.2003
Pros /cons in community-acquired pneumonia
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Summary
T. Welte (Magdeburg, Germany)
Source:
Annual Congress 2003 - Pros /cons in community-acquired pneumonia
Session:
Pros /cons in community-acquired pneumonia
Session type:
Major Symposium
Number:
1366
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Welte (Magdeburg, Germany). Summary. Annual Congress 2003 - Pros /cons in community-acquired pneumonia
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
Conclusion - Summary of the session
Source: Annual Congress 2008 - Outcome and trends in obstructive lung disease (OLD) and cardiovascular relation to OLD
Year: 2008
Summary and future developments
Source: Eur Respir Monogr 2010; 49: 247-249
Year: 2010
Use of Principal Component and Cluster Analysis to Describe Phenotypes in COPD.
Source: International Congress 2019 – COPD treatment: cohorts and real-world studies
Year: 2019
From the Museum: the Art of Thinking. Summary 9-12: Expressing out
Source: Eur Respir J 2015; 45: 1542-1543
Year: 2015
Forced Vital Capacity and Quality of Life: BOLD Study Cross-Sectional Analysis
Source: Virtual Congress 2021 – Patient-reported outcomes in respiratory disease
Year: 2021
From the Museum: the Art of Thinking. Summary 5-8: Sensing In
Source: Eur Respir J 2015; 45: 1226-1227
Year: 2015
Non Specific Spirometric Pattern: Evolving and associations with basic data
Source: Virtual Congress 2020 – Unusual tools for evaluating obstructive diseases
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept